Patient-focused pharma requires a risk- and science-based verification approach that supersedes the traditional phases of commissioning, qualification and the firmly established method of specified parameter range testing that includes worst-case scenarios. To deliver on the promise to patients, the holistic verification approach offers the potential for beneficial outcomes.